We are the winner of Medx@Düsseldorf startup competition 2021!

In a significant leap for artificial intelligence in healthcare, SmartAlpha, an innovative AI start-up specializing in ultrasound imaging, has emerged as the winner of the Medx@Düsseldorf startup competition 2021. Our participation in this esteemed event, coupled with our presence at MEDICA, the leading international trade fair, marked a pivotal moment in our mission to integrate AI into healthcare, particularly in ultrasound imaging.

At SmartAlpha, we’re not just developing AI technology; we’re pioneering a new era in ultrasound diagnostics. Our flagship product, Nerveblox, represents a breakthrough in this field. It’s one of the first AI solutions for ultrasound to receive the CE mark, affirming its approval for use across Europe. We’re now focused on obtaining FDA 510(k) approval to bring this innovative solution to the United States.

Our expertise doesn’t end with Nerveblox. We’ve established ourselves as leaders in musculoskeletal AI for ultrasound imaging. This technology offers unmatched precision, drastically improving diagnostics in complex cases involving muscles, bones, and joints.

In the rapidly evolving ultrasound AI landscape, we at SmartAlpha are at the forefront. We have developed specialized solutions across various domains, including anesthesiology, musculoskeletal (MSK), abdominal, and urology ultrasound AI. Each area poses unique challenges, and our AI solutions are designed to meet these needs effectively.

One of the cornerstones of our success is our commitment to clinical validation. We believe that AI in healthcare should not only be advanced in technology but also deeply rooted in practical, real-world medical applications. This approach ensures our solutions are not just innovative but also effective and reliable for clinical use.

Our victory at Medx@Düsseldorf 2021 is more than just an accolade; it’s a testament to our commitment to revolutionizing healthcare. Our AI-driven ultrasound imaging solutions are designed to enhance diagnostic accuracy, ease the workload of healthcare professionals, and ultimately lead to better patient outcomes. With our solutions already making a difference in Europe and soon in the U.S., we are excited about the potential impact we can have on global healthcare.

As we continue to innovate and expand our reach, our goal at SmartAlpha is to redefine global standards in ultrasound imaging. Our AI solutions, rigorously tested and compliant with regulatory standards, are poised to become indispensable tools for healthcare professionals worldwide.

In closing, our triumph at the Medx@Düsseldorf startup competition 2021 is a significant milestone for us at SmartAlpha. It emphasizes our role as a leader in AI-driven ultrasound imaging and showcases our suite of solutions across various ultrasound disciplines. We’re not just bringing AI into healthcare; we’re setting new benchmarks for innovation and efficacy in medical imaging. With SmartAlpha leading the way, the future of ultrasound diagnostics is here.

It’s perfect time to use AI in healthcare.

AI systems are able to learn incomparably faster than human beings. This allows us to develop artificial experts tutored in numerous institutes in a short time.

Subscribe for Newsletter

Nerveblox is a CE marked medical device which indicates that it meets EU safety, health and environmental protection requirements.It is not available for sale in United States and this content does not constitute a clinical benefit nor a commercial offer.

smartalpha logo
nerveblox certificate